Protective effect of proton‐pump inhibitor against gastrointestinal bleeding in patients receiving oral anticoagulants: A systematic review and meta‐analysis — Hyo‐Jeong Ahn (2022) | RDL Network
Protective effect of proton‐pump inhibitor against gastrointestinal bleeding in patients receiving oral anticoagulants: A systematic review and meta‐analysis
Article 2022 en
Authors
HA
Hyo‐Jeong Ahn
SL
So-Ryoung Lee
EC
Eue-Keun Choi
Abstract
1 min read
In patients who receive OAC, PPI cotherapy is associated with a lower total and major GIB irrespective of ethnic group and OAC type, except for edoxaban. PPI cotherapy can be considered particularly in patients with high risk of GIB.
Discussion(0)
No comments yet. Be the first to comment.